共 11 条
[1]
Surface properties determine bioadhensive outcomes: methods and results. Baier RE,Meyer AE,Natiella JR,et al. Journal of Biomedical Materials Research . 1984
[2]
Increase of gentamicin uptake in cultured mouse peritoneal macrophage and rat hepertocytes when used in the form of nanoparticles. Zhang Q,Liao GT,Wei DP,et al. Acta Pharmacological Sinica . 1996
[3]
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Gref R,Domb PQ,Blunk T,et al. Advanced Drug Delivery Reviews . 1995
[4]
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Siekmann B,Westesen K. European Journal of Pharmaceutics and Biopharmaceutics . 1996
[5]
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Gert S,Sheila DB,Toos D,et al. Advanced Drug Delivery Reviews . 1995
[6]
Solid lipid nanoparticles ( SLN )-an alternative colloidal carrier system for controlled drug delivery. Muller RH,Mehnert W,Lucks JS,et al. European Journal of Pharmaceutics and Biopharmaceutics . 1995
[7]
Surface and blood compatibility current hypotheses. Andrade JD,Nagaoka S,Coper S,et al. ASAIO Transactions American Society for Artificial Internal Organs . 1987
[8]
Studies on camptothecin solid lipid nanoparticles. Yang SC,Zhu JB,Liang BW,et al. Acta Pharmacological Sinica . 1999
[9]
The effect of hydrophillic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages. Illum L,Hunneyball IA,Davis SS. International Journal of Pharmaceutics . 1986
[10]
Relevant factors affecting the formation and growth of lipid nanospheres suspensions. Boltril L,Canal T,Esposito P,et al. European Journal of Pharmaceutics and Biopharmaceutics . 1995